MORANDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.836
EU - Europa 3.013
AS - Asia 1.957
SA - Sud America 312
AF - Africa 43
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.180
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.805
PL - Polonia 1.044
RU - Federazione Russa 890
SG - Singapore 624
CN - Cina 519
IT - Italia 418
HK - Hong Kong 327
BR - Brasile 247
KR - Corea 177
IE - Irlanda 156
SE - Svezia 142
VN - Vietnam 124
FI - Finlandia 93
DE - Germania 62
FR - Francia 49
GB - Regno Unito 41
ID - Indonesia 37
IN - India 36
ES - Italia 33
NL - Olanda 28
JO - Giordania 27
AR - Argentina 23
AU - Australia 17
EC - Ecuador 17
UA - Ucraina 16
ZA - Sudafrica 13
BD - Bangladesh 12
CH - Svizzera 12
BE - Belgio 11
CI - Costa d'Avorio 11
MX - Messico 11
TR - Turchia 11
CA - Canada 10
AE - Emirati Arabi Uniti 9
IQ - Iraq 9
JP - Giappone 8
CO - Colombia 6
TW - Taiwan 6
CL - Cile 5
MA - Marocco 5
MY - Malesia 5
UY - Uruguay 5
AT - Austria 4
BJ - Benin 4
GR - Grecia 4
PY - Paraguay 4
AZ - Azerbaigian 3
EG - Egitto 3
IL - Israele 3
PA - Panama 3
PK - Pakistan 3
SA - Arabia Saudita 3
VE - Venezuela 3
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
NP - Nepal 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AL - Albania 1
BG - Bulgaria 1
BO - Bolivia 1
CY - Cipro 1
EU - Europa 1
GL - Groenlandia 1
GT - Guatemala 1
KG - Kirghizistan 1
KI - Kiribati 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PH - Filippine 1
QA - Qatar 1
SN - Senegal 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 9.180
Salva come PNG Salva come JPEG
Città #
Warsaw 1.040
Santa Clara 836
Singapore 463
Fairfield 453
Ashburn 422
Hong Kong 290
Woodbridge 198
Houston 186
Seattle 186
Seoul 170
Cambridge 164
Dublin 156
Hefei 138
Chandler 134
Wilmington 127
Florence 126
Beijing 123
San Jose 106
Ann Arbor 90
Altamura 69
Lawrence 69
Helsinki 62
Princeton 43
Buffalo 41
Los Angeles 40
Ho Chi Minh City 35
Jakarta 32
Moscow 32
São Paulo 32
Medford 29
Shanghai 29
Paris 28
Dong Ket 27
Clifton 26
San Diego 26
Kent 25
Munich 23
The Dalles 23
Mumbai 22
Boston 20
Dallas 20
Barcelona 18
Hanoi 18
Melbourne 17
Phoenix 14
Frankfurt am Main 13
Milan 13
Bern 12
Boardman 12
Falls Church 12
New York 12
Abidjan 11
Brussels 11
London 11
Brooklyn 10
Lappeenranta 10
Belo Horizonte 9
Jacksonville 9
Redondo Beach 9
Tianjin 9
Yubileyny 9
Brasília 8
Chieri 8
Rome 8
Tokyo 8
Turku 8
Amman 7
Bengaluru 7
Chicago 7
Johannesburg 7
Turin 7
Baghdad 6
Donostia / San Sebastian 6
Guayaquil 6
Naples 6
Padua 6
San Francisco 6
Stockholm 6
Can Tho 5
Denver 5
Hangzhou 5
Orem 5
Quito 5
Redmond 5
Ribeirão Preto 5
Andover 4
Canicattì 4
Cotonou 4
Dearborn 4
Guangzhou 4
Hải Dương 4
Istanbul 4
Kilburn 4
Montevideo 4
Nuremberg 4
Qingdao 4
Redwood City 4
Zhengzhou 4
Amsterdam 3
Baku 3
Totale 6.610
Salva come PNG Salva come JPEG
Nome #
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 357
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts. 347
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 320
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. 312
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer 286
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells 267
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread 244
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 239
Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib 221
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer 221
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer 218
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts 205
Lactate modulates CD4 + T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis 196
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 193
Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival 191
Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance 189
Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy 189
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors. 185
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors 177
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 177
Senescent stroma promotes prostate cancer progression: The role of miR-210 173
Signaling pathways regulating redox balance in cancer metabolism 167
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 166
Linking metabolic reprogramming to therapy resistance in cancer 160
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer 158
Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer 155
Lactate: A Metabolic Driver in the Tumour Landscape 154
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes 151
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations 150
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 148
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 148
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 146
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 142
Metabolic implication of tumor:stroma crosstalk in breast cancer. 139
Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer 139
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer 138
Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism 138
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 137
RET in breast cancer: functional and therapeutic implications 137
GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors 137
Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk 135
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) 134
Targeting RET-interleukin-6 crosstalk to impair metastatic dissemination in breast cancer 132
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis 131
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence 129
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 114
A novel phage display based platform for exosome diversity characterization 112
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase 98
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers 96
Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance 89
CD44 and SLC1A2 are commonly regulated but do not form a fusion transcript in ER+ breast cancer 86
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 81
In vivo imaging of the spatial heterogeneity of intratumoral acidosis (pH) as a marker of the metastatic phenotype in breast cancer 80
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease 57
Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial 55
ESR1 Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer 19
Targeting carbonic anhydrase IX/XII prevents the anti-ferroptotic effect of stromal lactic acid in prostate carcinoma 15
Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes 11
Totale 9.291
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.757
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021425 0 0 0 0 0 0 49 48 85 147 48 48
2021/2022396 13 69 36 14 20 11 20 42 11 32 40 88
2022/2023778 62 190 44 41 49 137 96 35 69 9 27 19
2023/2024402 16 35 49 15 31 23 20 102 28 22 31 30
2024/20252.606 84 234 153 383 695 365 64 191 111 76 100 150
2025/20262.295 343 446 354 359 450 131 212 0 0 0 0 0
Totale 9.291